Anticonvulsant and adverse effects of MK-801, LY 235959, and GYKI 52466 in combination with Ca2+ channel inhibitors in mice

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 4, 1997, Pages 629-635

  Gasior, Maciej ^a   Borowicz, Kinga ^a   Kleinrok, ZdzisŁaw ^a   Starownik, RadosŁaw ^a   Czuczwar, StanisŁaw J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

calcium channel inhibitors; GYKI 52466; LY 235959; MK 801; seizures

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; FLUNARIZINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICARDIPINE; NIFEDIPINE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG POTENTIATION; ELECTRIC SHOCK; HINDLIMB; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING DISORDER; LONG TERM MEMORY; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTECTION; SEIZURE THRESHOLD; TONIC SEIZURE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; AVOIDANCE LEARNING; BENZODIAZEPINES; CALCIUM CHANNEL BLOCKERS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; FLUNARIZINE; ISOQUINOLINES; MALE; MICE; MOTOR ACTIVITY; NICARDIPINE; NIFEDIPINE; SEIZURES;

ANIMALIA;

EID: 0030972348     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00405-4     Document Type: Article

References (33)

1. Binnie, C. D.: Potential antiepileptic drugs. Flunarizine and other calcium entry blockers. In: Levin, R. H.; Dreifuss, F. E.; Mattson, R. H.; Meldrum, B. S.; Penry, J. K., eds. Antiepileptic drugs, 3rd ed. New York: Raven Press, 1989:971-982.
2. Boissier J. R., Tardy J., Diverres J. C. Une nouvelle methode simple pour explorer l'action 'tranquilisante'. Le test de la cheminee Med. Exp. (Basel). 3:1960;81-84.
3. Borowicz K. K., Gasior M., Kleinrok Z., Czuczwar S. J. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur. J. Pharmacol. 281:1995;319-326.
4. Clineschmidt B. V., Martin G. E., Bunting P. R., Papp M. L. Central sympathomimetic activity of (±)-5-methyl-10,11-dihydro-5H-dibenzo-(a,d)cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev. Res. 2:1982;135-145.
5. Cunningham M. D., Ferkany J. W., Enna S. J. Excitatory amino acid receptors. A gallery of new targets for pharmacological intervention Life Sci. 54:1993;135-148.
6. Czechowska G., Dziki M., Pietrasiewicz T., Kleinrok Z., Turski W. A., Czuczwar S. J. Competitive antagonists of NMDA receptor. CGP 37849 and CGP 39551 enhance the antielectroshock activity of valproate against electroconvulsions in mice Eur. J. Pharmacol. 232:1993;59-64.
7. Czuczwar S. J., Borowicz K. K., Kleinrok Z., Tutka P., Żarnowski T., Turski W. A. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice. Eur. J. Pharmacol. 281:1995;327-333.
8. Czuczwar S. J., Chodkowska A., Kleinrok Z., Małek U., Jagiełło-Wójtowicz E. Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. Eur. J. Pharmacol. 176:1990;75-83.
9. Czuczwar S. J., Gasior M., Janusz W., Kleinrok Z. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology. 31:1992;1179-1183.
10. 2+ channel agonist, BAY k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists. Eur. J. Pharmacol. 264:1994;103-106.
11. Czuczwar S. J., Małek U., Kleinrok Z. Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology. 29:1990;943-948.
12. Gasior M., Borowicz K., Starownik R., Kleinrok Z., Czuczwar S. J. Nicardipine, nifedipine and flunarizine enhance the antielectroshock activity of two competitive NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice. Eur. J. Pharmacol. 312:1996;27-33.
13. Gasior M., Kleinrok Z., Czuczwar S. J. Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional anti-epileptics against electroconvulsions in mice. Neuropharmacology. 34:1995;433-438.
14. Hayashi T. Effects of sodium glutamate on the nervous system. Keio J. Med. 3:1954;183-192.
15. Heinemann U., Hamon B. Calcium and epileptogenesis. Exp. Brain Res. 65:1986;1-10.
16. 2+ channels can transiently potentiate excitatory synaptic transmission in the hippocampus. Neuron. 9:1992;1175-1183.
17. Litchfield J. T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
18. Lodge D. Modulation of N-methylaspartate receptor-channel complexes. Drugs Today. 25:1989;395-411.
19. Löscher W., Rundfeldt C., Hönack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effects of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 5:1993;1545-1550.
20. Parada-Turska J., Turski W. A. Excitatory amino acid antagonists and memory. Effects of drugs acting at N-methyl-D-aspartate receptors in learning and memory Neuropharmacology. 29:1990;1111-1116.
21. Phillis J. W., Wu P. H., Coffin V. L. Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds. Gen. Pharmacol. 14:1983;475-479.
22. Pietrasiewicz T., Czechowska G., Dziki M., Turski W. A., Kleinrok Z., Czuczwar S. J. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics. Eur. J. Pharmacol. 250:1993;1-7.
23. Rogawski M. A. Excitatory amino acids and seizures. Stone T. W. CNS neurotransmitters and neuromodulators. Glutamate:1995;219-237 CRC Press, Boca Raton, FL.
24. Rogawski M. A., Porter R. J. Antiepileptic drugs. Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds Pharmacol. Rev. 42:1990;223-286.
25. Skeen G. A., Twyman R. E., White H. S. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol. Pharmacol. 44:1993;443-450.
26. Sommer B., Seeburg P. Glutamate receptor channels. Novel properties and new clones Trends Pharmacol. Sci. 13:1992;291-296.
27. Urbańska E., Dziki M., Kleinrok Z., Czuczwar S. J., Turski W. A. Influence of MK-801 on the anticonvulsant activity of antiepileptics. Eur. J. Pharmacol. 200:1991;277-282.
28. Venault P., Chapouthier G., De Carvalho L. P., Simiand J., Morre M., Dodd R. H., Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature. 321:1986;864-866.
29. 2+-dependent transmitter release Prog. Neurobiol. 42:1994;539-574.
30. Witkin J. M. Role of NMDA receptors in behavior and behavioral effects of drugs. Stone T. W. CNS neurotransmitters and neuromodulators. Glutamate:1995;323-350 CRC Press, Boca Raton, FL.
31. Wroblewski J. T., Danysz W. Modulation of glutamate receptors. Molecular mechanisms and functional implications Annu. Rev. Pharmacol. Toxicol. 29:1989;441-474.
32. Żarnowski T., Kleinrok Z., Czuczwar S. J. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology. 33:1994;619-624.
33. Żarnowski T., Kleinrok Z., Turski W. A., Czuczwar S. J. 2,3-Dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. Neuropharmacology. 32:1993;895-900.